Search research articles
Contact Us
Filters
Showing results (71-80 of 234) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors
Gerald Batist, Karen A Gelmon, Kim N Chi, et al.
European Urology
|
February 11, 2014
Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status
Arun A Azad, Bernhard J Eigl, Raya Leibowitz-Amit, et al.
International Journal of Cancer
|
November 5, 2011
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
Luke A Selth, Scott Townley, Joanna L Gillis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer
Kim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
European Urology
|
December 29, 2018
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial
Daniel J Khalaf, Katherine Sunderland, Bernhard J Eigl, et al.
Clinical Genitourinary Cancer
|
August 29, 2017
Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone
Charles J Ryan, Thian Kheoh, Jinhui Li, et al.
Lab on a Chip
|
April 16, 2015
Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps
Xi Qin, Sunyoung Park, Simon P Duffy, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
January 31, 2018
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Daniel Joseph Khalaf, Claudia M Avilés, Arun A Azad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial
Jimmy L Zhao, Karim Fizazi, Fred Saad, et al.
The Prostate
|
September 2, 2014
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer
Arun A Azad, Raya Leibowitz-Amit, Bernhard J Eigl, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 234) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors
Gerald Batist, Karen A Gelmon, Kim N Chi, et al.
European Urology
|
February 11, 2014
Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status
Arun A Azad, Bernhard J Eigl, Raya Leibowitz-Amit, et al.
International Journal of Cancer
|
November 5, 2011
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
Luke A Selth, Scott Townley, Joanna L Gillis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer
Kim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
European Urology
|
December 29, 2018
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial
Daniel J Khalaf, Katherine Sunderland, Bernhard J Eigl, et al.
Clinical Genitourinary Cancer
|
August 29, 2017
Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone
Charles J Ryan, Thian Kheoh, Jinhui Li, et al.
Lab on a Chip
|
April 16, 2015
Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps
Xi Qin, Sunyoung Park, Simon P Duffy, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
January 31, 2018
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Daniel Joseph Khalaf, Claudia M Avilés, Arun A Azad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial
Jimmy L Zhao, Karim Fizazi, Fred Saad, et al.
The Prostate
|
September 2, 2014
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer
Arun A Azad, Raya Leibowitz-Amit, Bernhard J Eigl, et al.
Page
of 24